{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T02:37:57Z","timestamp":1776911877358,"version":"3.51.2"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Thiamine-responsive megaloblastic anemia syndrome represents a rare autosomal recessive condition originating from mutations in the SLC19A2 gene. It is characterized by a classical triad of megaloblastic anemia, insulin-dependent diabetes mellitus, and sensorineural hearing loss. We present the case of a woman diagnosed with thiamine-responsive megaloblastic anemia, with no history of consanguinity, in whom genetic testing revealed novel SLC19A2 mutations and an unreported clinical manifestation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case Presentation<\/jats:title>\n                    <jats:p>This case describes an 18-year-old mestizo female patient who presented with a medical history of diabetes starting in infancy, bilateral sensorineural hearing loss, and megaloblastic anemia. The diagnosis of thiamine-responsive megaloblastic anemia was confirmed by genetic testing, which detected compound heterozygous mutations in the SLC19A2 gene that included a pathogenic frameshift mutation (c.620_624dup; p.Pro209Phefs*21) and a missense variant (c.170\u00a0T\u2009&gt;\u2009C; p.Leu57Pro). The patient also experienced thrombotic events, including deep vein and mesenteric thrombosis, previously unreported findings in thiamine-responsive megaloblastic anemia. High-dose thiamine treatment resulted in improved hematologic and glycemic control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case broadens the genetic and clinical spectrum of thiamine-responsive megaloblastic anemia, highlighting the importance of genetic testing in young patients with the classic triad and showing that early thiamine therapy can markedly improve outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13256-026-05960-w","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T14:55:04Z","timestamp":1773672904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thiamine-responsive megaloblastic anemia syndrome with novel compound heterozygous SLC19A2 mutations and thrombotic events: a case report"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2159-0583","authenticated-orcid":false,"given":"Francisco Xavier","family":"Jim\u00e9nez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4401-4036","authenticated-orcid":false,"given":"Carlos","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2371-2604","authenticated-orcid":false,"given":"Heidi A.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3167-5341","authenticated-orcid":false,"given":"Rossana","family":"Ruiz-Urb\u00e1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1141-3279","authenticated-orcid":false,"given":"Carlos","family":"Reyes-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8390-371X","authenticated-orcid":false,"given":"Jhonatan","family":"Guam\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4368-9621","authenticated-orcid":false,"given":"Mauricio","family":"Carri\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9545-2477","authenticated-orcid":false,"given":"Fernando","family":"Naranjo-Saltos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"5960_CR1","volume-title":"GeneReviews","author":"K Oishi","year":"2003","unstructured":"Oishi K, Diaz GA, et\u00a0al. Thiamine-responsive megaloblastic anemia syndrome. In: Adam MP, Ardinger HH, Pagon RA, et\u00a0al., editors. GeneReviews. Seattle; 2003."},{"issue":"12","key":"5960_CR2","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/adc.2003.036608","volume":"89","author":"JR Porter","year":"2004","unstructured":"Porter JR, Barrett TG. Acquired non-type 1 diabetes in childhood: subtypes, diagnosis, and management. Arch Dis Child. 2004;89(12):1138\u201344. https:\/\/doi.org\/10.1136\/adc.2003.036608.","journal-title":"Arch Dis Child"},{"issue":"3","key":"5960_CR3","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/10372","volume":"22","author":"V Labay","year":"1999","unstructured":"Labay V, Raz T, Baron D, Mandel H, Williams H, Barrett T, et\u00a0al. Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness. Nat Genet. 1999;22(3):300\u20134. https:\/\/doi.org\/10.1038\/10372.","journal-title":"Nat Genet"},{"key":"5960_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cca.2021.01.025","volume":"516","author":"S Zhang","year":"2021","unstructured":"Zhang S, Yu Q, Zengmin W, Jianxin Z, Yan S, Xiaohong S, et\u00a0al. Identification of novel compound heterozygous variants in SLC19A2 and the genotype-phenotype associations in thiamine-responsive megaloblastic anemia. Clin Chim Acta. 2021;516:157\u201368. https:\/\/doi.org\/10.1016\/j.cca.2021.01.025.","journal-title":"Clin Chim Acta"},{"issue":"5","key":"5960_CR5","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2337\/db17-0821","volume":"68","author":"P Jungtrakoon","year":"2019","unstructured":"Jungtrakoon P, Shirakawa J, Buranasupkajorn P, Gupta MK, De Jesus DF, Pezzolesi MG, et\u00a0al. Loss-of-function mutation in thiamine transporter 1 in a family with autosomal dominant diabetes. Diabetes. 2019;68(5):1084\u201393. https:\/\/doi.org\/10.2337\/db17-0821.","journal-title":"Diabetes"},{"key":"5960_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.630329","volume":"9","author":"P Kang","year":"2021","unstructured":"Kang P, Zhang W, Wen J, Zhang J, Li F, Sun W. Case report: genetic and clinical features of maternal uniparental isodisomy-induced thiamine-responsive megaloblastic anemia syndrome. Front Pediatr. 2021;9: 630329. https:\/\/doi.org\/10.3389\/fped.2021.630329.","journal-title":"Front Pediatr"},{"key":"5960_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjd.2020.11.006","author":"K Warncke","year":"2020","unstructured":"Warncke K, Prinz N, Iotova V, Dunstheimer D, Datz N, Karges B, et\u00a0al. Thiamine-responsive megaloblastic anemia related diabetes: long-term clinical outcomes in 23 patients from DPV and SWEET registries. Can J Diabetes. 2020. https:\/\/doi.org\/10.1016\/j.jcjd.2020.11.006.","journal-title":"Can J Diabetes"},{"key":"5960_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-019-1608-2","volume":"19","author":"X Li","year":"2019","unstructured":"Li X, Cheng Q, Ding Y, Li Q, Yao R, Wang J, et\u00a0al. TRMA syndrome with a severe phenotype, cerebral infarction, and novel compound heterozygous SLC19A2 mutation: a case report. BMC Pediatr. 2019;19: 233. https:\/\/doi.org\/10.1186\/s12887-019-1608-2.","journal-title":"BMC Pediatr"},{"issue":"7","key":"5960_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/biology12071008","volume":"12","author":"D Gurung","year":"2023","unstructured":"Gurung D, Danielson JA, Tasnim A, Zhang J-T, Zou Y, Liu J-Y. Proline isomerization: from the chemistry and biology to therapeutic opportunities. Biology. 2023;12(7): 1008. https:\/\/doi.org\/10.3390\/biology12071008.","journal-title":"Biology"},{"key":"5960_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2018.06.005","author":"H Lu","year":"2018","unstructured":"Lu H, Vaucher J, Tran C, Vollenweider P, Castioni J. L\u2019an\u00e9mie m\u00e9galoblastique thiamine d\u00e9pendante ou syndrome de Rogers: une revue de la litt\u00e9rature. Rev Med Interne. 2018. https:\/\/doi.org\/10.1016\/j.revmed.2018.06.005.","journal-title":"Rev Med Interne"},{"key":"5960_CR11","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s00125-018-4554-x","volume":"61","author":"A Habeb","year":"2018","unstructured":"Habeb A, Flanagan S, Zulali M, Abdullah M, Pomaha\u010dov\u00e1 R, Boyadzhiev V, et\u00a0al. Pharmacogenomics in diabetes: outcomes of thiamine therapy in TRMA syndrome. Diabetologia. 2018;61:1027\u201336. https:\/\/doi.org\/10.1007\/s00125-018-4554-x.","journal-title":"Diabetologia"},{"key":"5960_CR12","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1159\/000491467","volume":"47","author":"X Xian","year":"2018","unstructured":"Xian X, Liao L, Shu W, Li H, Qin Y, Yan J, et\u00a0al. A novel mutation of SLC19A2 in a Chinese Zhuang ethnic family with thiamine-responsive megaloblastic anemia. Cell Physiol Biochem. 2018;47:1989\u201397. https:\/\/doi.org\/10.1159\/000491467.","journal-title":"Cell Physiol Biochem"},{"key":"5960_CR13","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s00125-018-4554-x","volume":"61","author":"AM Habeb","year":"2018","unstructured":"Habeb AM, Flanagan SE, Zulali MA, et\u00a0al. Pharmacogenomics in diabetes: outcomes of thiamine therapy in TRMA syndrome. Diabetologia. 2018;61:1027\u201336. https:\/\/doi.org\/10.1007\/s00125-018-4554-x.","journal-title":"Diabetologia"},{"issue":"3","key":"5960_CR14","first-page":"12","volume":"37","author":"JU Rehman","year":"2022","unstructured":"Rehman JU, AlJohani NI, Momin N, Muddassir S, Hawsawi YM. Thiamine deficiency syndrome (rogers syndrome) with recurrent thrombosis and pulmonary embolism with a novel mutation. Oman Med J. 2022;37(3):12.","journal-title":"Oman Med J."},{"issue":"3","key":"5960_CR15","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1210\/jcem.85.3.6419","volume":"85","author":"V Villa","year":"2000","unstructured":"Villa V, Rivellese A, Di Salle F, Iovine C, Poggi V, Capaldo B. Acute ischemic stroke in a young woman with the thiamine-responsive megaloblastic anemia syndrome. J Clin Endocrinol Metab. 2000;85(3):947\u20139. https:\/\/doi.org\/10.1210\/jcem.85.3.6419.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-026-05960-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-05960-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-05960-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T01:54:44Z","timestamp":1776909284000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13256-026-05960-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5960"],"URL":"https:\/\/doi.org\/10.1186\/s13256-026-05960-w","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"3 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our institution does not require ethics committee approval for case report analyses of patient records.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"218"}}